Understanding the leptin and cholesterol metabolism in the fetus and neonates is very critical, not only for the nourishment of neonates but also for the strategies to decrease the future recognized risk of cardiovascular diseases (CVD) in fetuses with IUGR.2 The gene discussed is LEP; the disease is fetal growth restriction.